cbdMD (YCBD) Assets Average (2016 - 2025)
cbdMD (YCBD) reported Assets Average of $11.1 million for Q4 2025, little changed on a YoY basis from $11.1 million in Q4 2024, and up 9.29% sequentially from $10.2 million in Q3 2025.
cbdMD (YCBD) Assets Average (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Assets Average data on file, last reported at $11.1 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average changed 0.35% year-over-year to $11.1 million; the trailing twelve-month figure through Dec 2025 stood at $11.1 million (changed 0.35% YoY), and the FY2025 full-year result was $10.5 million, down 21.57% from the prior year.
- Assets Average climbed to $11.1 million in Q4 2025, from $10.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $122.6 million in Q1 2021 to a low of $10.2 million in Q3 2025.
- A 5-year average of $46.8 million and a median of $29.0 million in 2023 frame the typical range for Assets Average.
- Across the five-year window, Assets Average gained 14.35% in 2021 and sank 65.87% in 2022, its largest moves.
- Tracing YCBD's Assets Average over 5 years: stood at $112.1 million in 2021, then slumped by 65.87% to $38.3 million in 2022, then plunged by 59.11% to $15.6 million in 2023, then decreased by 29.29% to $11.1 million in 2024, then climbed by 0.35% to $11.1 million in 2025.
- Business Quant data shows YCBD's Assets Average at $11.1 million in Q4 2025, $10.2 million in Q3 2025, and $10.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 11.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.10 Mn |
| Sep 30, 2025 | 10.16 Mn |
| Jun 30, 2025 | 10.42 Mn |
| Mar 31, 2025 | 11.24 Mn |
| Dec 31, 2024 | 11.06 Mn |
| Sep 30, 2024 | 12.21 Mn |
| Jun 30, 2024 | 14.20 Mn |
| Mar 31, 2024 | 14.82 Mn |
| Dec 31, 2023 | 15.65 Mn |
| Sep 30, 2023 | 24.58 Mn |
| Jun 30, 2023 | 33.33 Mn |
| Mar 31, 2023 | 34.71 Mn |
| Dec 31, 2022 | 38.26 Mn |
| Sep 30, 2022 | 48.96 Mn |
| Jun 30, 2022 | 75.06 Mn |
| Mar 31, 2022 | 96.16 Mn |
| Dec 31, 2021 | 112.11 Mn |
| Sep 30, 2021 | 120.20 Mn |
| Jun 30, 2021 | 118.29 Mn |
| Mar 31, 2021 | 122.57 Mn |